Ýmis lyf 80 Æxlishemjandi lyf
Awarded
The competition has ended and a winner has been selected.
- Award
- Procedure
- OpenSingle stage
Brief
Landspítali Háskólasjúkrahús has entered into a framework agreement with Icepharma, Vistor, Alvogen ehf, Williams & Halls ehf, and Icepharma Pfizer for the delivery of various pharmaceutical products, specifically antineoplastic drugs, to the Capital Region of Iceland. The agreement has a duration of 2 years and a maximum total value of 13.8 billion Icelandic Króna. The award was based on quality, and 29 bids were received.
Farmasøytisk engroshandel
Result
- Alvogen ehfWinner
- IcepharmaWinner
- IcepharmaWinner
- Icepharma PfizerWinner
- VistorWinner
- 29Number of tenders received
- ISK 0Contract value
- Maximum framework agreement valueUp to ISK 13,800,000,000
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Landspítali Háskólasjúkrahús
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Se anbudsdokumenter for detaljer.
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
Landspítali University hospital calls for tender for various drugs. Further description is in the Tender Documents available electronically from the Mercell Tendsign procurement portal.
Contact
Ragnar Davíðssonragnard@landspitali.is- Result · Framework agreementType
- HöfuðborgarsvæðiLocation
- 33600000Main codePharmaceutical products